5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Por um escritor misterioso
Descrição
Niemann–Pick is a rare autosomal recessive inherited disease that is characterized by excessive accumulation of cholesterol and lipids in cells, leading to apoptosis and neural degeneration. The disease affects numerous body parts such as the brain, nerves, liver, spleen, bone marrow and lungs. Those suffering from the disease suffer from lack of coordination, dystonia; sleep disturbances, difficult in eating and swallowing and frequent bouts of pneumonia.
Valley family fights for drug to save sick child
Niemann-Pick Canada (@NP_Canada) / X
Toddler with 'childhood Alzheimer's' symptoms gets experimental treatment - ABC News
Topic · Rare disease awareness ·
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Cellular Penetration and Intracellular Dynamics of Perfluorocarbon-Conjugated DNA/RNA as a Potential Means of Conditional Nucleic Acid Delivery
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS - The Lancet Child & Adolescent Health
Every Cure Announces Leaders Across Healthcare Joining its Board of Directors
This Post is for Laurie
Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Recent advances in the treatment of Niemann pick disease type C: A mini-review - ScienceDirect
New therapies for Niemann-Pick Disease Type C treatment by DelveInsight Business Research LLP., DelveInsight Business Research LLP posted on the topic
Frontiers Fountain of youth—Targeting autophagy in aging